Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-Current Assets (2019 - 2026)

Biodesix filings provide 8 years of Non-Current Assets readings, the most recent being $53.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 5.11% to $53.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $53.7 million, a 5.11% decrease, with the full-year FY2025 number at $55.0 million, down 4.85% from a year prior.
  • Non-Current Assets hit $53.7 million in Q1 2026 for Biodesix, down from $55.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $59.4 million in Q4 2023 to a low of $34.4 million in Q1 2022.
  • Median Non-Current Assets over the past 5 years was $55.3 million (2025), compared with a mean of $51.7 million.
  • Biggest five-year swings in Non-Current Assets: surged 50.14% in 2023 and later dropped 5.8% in 2025.
  • Biodesix's Non-Current Assets stood at $39.6 million in 2022, then surged by 50.14% to $59.4 million in 2023, then dropped by 2.78% to $57.8 million in 2024, then dropped by 4.85% to $55.0 million in 2025, then decreased by 2.24% to $53.7 million in 2026.
  • The last three reported values for Non-Current Assets were $53.7 million (Q1 2026), $55.0 million (Q4 2025), and $55.3 million (Q3 2025) per Business Quant data.